Peter D Urrea is currently working in the Taiho Pharma USA, Inc.. Princeton, NJ, USA. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work.
|
Dihydrouracil Dehydrogenase (NADP), Fluorouracil, gemcitabine, Pancreas, Pancreatic Neoplasms, S 1 (combination) |